Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. Cronos Group Inc.
  6. Summary
    CRON   CA22717L1013

CRONOS GROUP INC.

(CRON)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Toronto Stock Exchange
10/19/2021 10/20/2021 10/21/2021 10/22/2021 10/25/2021 Date
7.22(c) 7.17(c) 7.36(c) 6.96(c) 6.89(c) Last
609 777 446 146 412 303 314 902 223 486 Volume
+8.41% -0.69% +2.65% -5.43% -1.01% Change
More quotes
Estimated financial data (e)
Sales 2021 87,1 M 70,4 M 70,4 M
Net income 2021 -220 M -178 M -178 M
Net cash position 2021 1 130 M 913 M 913 M
P/E ratio 2021 -11,6x
Yield 2021 -
Sales 2022 151 M 122 M 122 M
Net income 2022 -187 M -151 M -151 M
Net cash position 2022 1 123 M 907 M 907 M
P/E ratio 2022 -17,1x
Yield 2022 -
Capitalization 2 572 M 2 079 M 2 078 M
EV / Sales 2021 16,5x
EV / Sales 2022 9,57x
Nbr of Employees 631
Free-Float 52,1%
More Financials
Company
Cronos Group Inc is a cannabinoid company. The Company is focused on cannabis research, technology and product development. The CompanyÔÇÖs portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones and PEACE+ are hemp-derived cannabidiol (CBD) brands. The CompanyÔÇÖs segments include United States and... 
Sector
Pharmaceuticals
Calendar
11/05 | 01:30pmPresentation
More about the company
Ratings of Cronos Group Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about CRONOS GROUP INC.
10/25IRWIN NATURALS : Plans Entry into THC Side of Cannabis Market; Set Up unit for Psychedelic..
MT
10/25Piper Sandler Sees Key Opportunities, Near-Term Volatility for Cannabis Industry as US ..
MT
10/25RED WHITE & BLOOM BRANDS : & Bloom Says Certain Holders of Preferred Shares Agree to Locku..
MT
10/25FIRE & FLOWER : Settles Debt Facilities with ATB Financial
MT
10/25INTERCURE : Details Record Preliminary Q3 Revs of C$24 million, Three Times YoY and 36% Qo..
MT
10/25HIGH TIDE : Down In US Pre-Market Although Expands Canna Cabana Store Footprint in Saskatc..
MT
10/25HIGH TIDE : Opens Two New Retail Cannabis Stores in Saskatchewan, Ontario
MT
10/25InterCure Reports Higher Preliminary Q3 Revenue
MT
10/25CRESO PHARMA : Acquires Canadian Life Sciences Company's Assets to Strengthen North Americ..
MT
10/22HERITAGE CANNABIS : Reports Note, Warrant Purchase Agreement with Merida Capital; Falls 7...
MT
10/22AVICANNA : Completes Export to Chile of Cannabis Derivatives from Colombian Unit
MT
10/21NEUROTECH INTERNATIONAL : Completes Preclinical Studies of Medical Cannabis in Multiple Sc..
MT
10/21S&P/TSX COMPOSITE INDEX : Canada Stocks Close at Another Record as Industrials, Tech, Stre..
MT
10/21SUNNIVA : Running Out of Cash, to Seek Regulatory Approval for Special Private Placement
MT
10/21CRONOS GROUP LAUNCHES ITS FIRST CULT : 1 THC|CBG Gummy
AQ
More news
News in other languages on CRONOS GROUP INC.
10/25Drogenbeauftragte warnt vor Legalisierung von Cannabis
10/25AYURCANN HOLDINGS CORP. : Ayurcann Holdings Corp. setzt seine Strategie hinsichtlich mediz..
10/25InterCure annonce des revenus préliminaires records de 24 millions de dollars canadiens..
10/25TRUE LEAF BRANDS INC. : True Leaf sichert sich zusätzliche Fremdmittel für strategische Pr..
10/25HIGH TIDE INC. : High Tide baut seine ,Canna Cabana'-Geschäftsstandorte in den Provinzen S..
More news
Analyst Recommendations on CRONOS GROUP INC.
More recommendations
Chart CRONOS GROUP INC.
Duration : Period :
Cronos Group Inc. Technical Analysis Chart | CRON | CA22717L1013 | MarketScreener
Technical analysis trends CRONOS GROUP INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Last Close Price 6,89 CAD
Average target price 8,40 CAD
Spread / Average Target 21,9%
EPS Revisions
Managers and Directors
Kurt T. Schmidt President & Chief Executive Officer
Robert L. Madore Chief Financial Officer
Michael Ryan Gorenstein Executive Chairman
Jason Marc Adler Independent Director
James D. Rudyk Lead Independent Director
Sector and Competitors